pepsico glp 1 GLP-1 drug threat “negligible” to PepsiCo, CEO says PepsiCo CEO: GLP-1 drugs are

Although dedicated trials of GLP-1RAs in AITD are lacking, preliminary reports suggest potential impact on thyroid volume, thyroid function, and autoimmune activity

doi: 10.1210/endrev/bnz002 43 AmbatiSDuanJHartzellDLChoiYHDella-FeraMABaileCA

For long-acting GLP-1 RAs, 8% to 16% patients treated with Tanzeum had injection site reactions [122, 137, 149-152]

Incidence of diabetic retinopathy did not differ between the orforglipron and placebo groups, and no hepatic safety signals were observed in the trial

Vitamin B12 (cyanocobalamin or methylcobalamin) is often included to address fatigue and support energy metabolism